Qualification of Drivers; Exemption Applications; Diabetes, 63041-63042 [E8-25172]
Download as PDF
Federal Register / Vol. 73, No. 205 / Wednesday, October 22, 2008 / Notices
Hawaii,
Illinois,
Louisiana,
Maine,
Maryland,
Massachusetts,
Michigan,
Minnesota,
New Hampshire,
New Jersey,
New York,
Ohio,
Pennsylvania,
Rhode Island,
Texas,
Utah,
Vermont,
Virginia,
West Virginia,
Wisconsin.
Please note that two States have been
removed from the previous list of
approved programs. Arkansas no longer
has a periodic inspection program for
buses comparable to, or as effective, as
the Federal PI program. Oklahoma has
repealed its inspection requirements.
Both States have therefore been delisted. As required by 49 CFR
396.23(b)(2), each motor carrier in
Arkansas and Oklahoma must ensure
that the periodic inspection required by
49 CFR 396.17 is performed on all
CMVs under its control.
In addition to the States listed above,
the FMCSA accepts the inspection
programs of the 10 Canadian Provinces
(Alberta, British Columbia, Manitoba,
New Brunswick, Newfoundland, Nova
Scotia, Ontario, Prince Edward Island,
Quebec and Saskatchewan) and the
Yukon Territory are comparable to, or as
effective as, the Federal PI requirements.
All other States either have no PI
programs for CMVs or their PI programs
have not been determined by the
FMCSA to be comparable to, or as
effective as, the Federal PI requirements.
Should any of these States wish to
establish a program or modify their
programs in order to make them
comparable to the Federal requirements,
the State should contact the appropriate
FMCSA division office.
List of Subjects
sroberts on PROD1PC70 with NOTICES
Highway safety, Highways and roads,
Motor carriers, Motor vehicle
maintenance, Motor vehicle safety,
Reporting and recordkeeping
requirements.
Authority: 49 U.S.C. 31132, 31136, 31142,
31502, and 31504; 49 CFR 1.73.
Issued on: October 14, 2008.
John H. Hill,
Administrator.
[FR Doc. E8–25174 Filed 10–21–08; 8:45 am]
BILLING CODE 4910–EX–P
VerDate Aug<31>2005
17:50 Oct 21, 2008
Jkt 217001
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2008–0267]
Qualification of Drivers; Exemption
Applications; Diabetes
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
SUMMARY: FMCSA announces its
decision to exempt thirty-nine
individuals from its rule prohibiting
persons with insulin-treated diabetes
mellitus (ITDM) from operating
commercial motor vehicles (CMVs) in
interstate commerce. The exemptions
will enable these individuals to operate
CMVs in interstate commerce.
DATES: The exemptions are effective
October 22, 2008. The exemptions
expire on October 22, 2010.
FOR FURTHER INFORMATION CONTACT: Dr.
Mary D. Gunnels, Director, Medical
Programs, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
Transportation, 1200 New Jersey
Avenue, SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey
Avenue, SE., Washington, DC, between
9 a.m. and 5 p.m., Monday through
Friday, except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
complete Privacy Act Statement in the
Federal Register (65 FR 19476, Apr. 11,
2000). This statement is also available at
https://Docketsinfo.dot.gov.
Background
On September 9, 2008, FMCSA
published a notice announcing receipt
of applications for exemption from the
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
63041
Federal diabetes standard from thirtynine individuals, and requested
comments from the public (73 FR
52451). The public comment period
closed on October 9, 2008, and no
comments were received.
FMCSA has evaluated the eligibility
of the thirty-nine applicants and
determined that granting the
exemptions to these individuals would
achieve a level of safety equivalent to,
or greater than, the level that would be
achieved by complying with the current
regulation 49 CFR 391.41(b)(3).
Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
standard for diabetes in 1970 because
several risk studies indicated that
diabetic drivers had a higher rate of
crash involvement than the general
population. The diabetes rule provides
that ‘‘A person is physically qualified to
drive a commercial motor vehicle if that
person has no established medical
history or clinical diagnosis of diabetes
mellitus currently requiring insulin for
control’’ (49 CFR 391.41(b)(3)).
FMCSA established its diabetes
exemption program, based on the
Agency’s July 2000 study entitled ‘‘A
Report to Congress on the Feasibility of
a Program to Qualify Individuals with
Insulin-Treated Diabetes Mellitus to
Operate in Interstate Commerce as
Directed by the Transportation Act for
the 21st Century.’’ The report concluded
that a safe and practicable protocol to
allow some drivers with ITDM to
operate CMVs is feasible. The 2003
Notice (68 FR 52442) in conjunction
with the November 8, 2005 (70 FR
67777) Federal Register Notice provides
the current protocol for allowing such
drivers to operate CMVs in interstate
commerce.
These thirty-nine applicants have had
ITDM over a range of 1 to 24 years.
These applicants report no
hypoglycemic reaction that resulted in
loss of consciousness or seizure, that
required the assistance of another
person, or that resulted in impaired
cognitive function without warning
symptoms in the past 5 years (with one
year of stability following any such
episode). In each case, an
endocrinologist has verified that the
driver has demonstrated willingness to
properly monitor and manage his or her
diabetes, received education related to
diabetes management, and is on a stable
insulin regimen. Each driver reports no
other disqualifying conditions,
including diabetes-related
complications. Each meets the vision
standard at 49 CFR 391.41(b)(10).
E:\FR\FM\22OCN1.SGM
22OCN1
63042
Federal Register / Vol. 73, No. 205 / Wednesday, October 22, 2008 / Notices
The qualifications and medical
condition of each applicant were stated
and discussed in detail in the
September 9, 2008, Federal Register
Notice (73 FR 52451). Therefore, they
will not be repeated in this notice.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the diabetes standard in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
To evaluate the effect of these
exemptions on safety, FMCSA
considered medical reports about the
applicants’ ITDM and vision and
reviewed the treating endocrinologist’s
medical opinion related to the ability of
the driver to safely operate a CMV while
using insulin.
Consequently, FMCSA finds that
exempting these applicants from the
diabetes standard in 49 CFR 391.41(b)(3)
is likely to achieve a level of safety
equal to that existing without the
exemption.
sroberts on PROD1PC70 with NOTICES
Conditions and Requirements
The terms and conditions of the
exemption will be provided to the
applicants in the exemption document
and they include the following: (1) That
each individual submits to FMCSA a
quarterly monitoring checklist
completed by the treating
endocrinologist as well as an annual
checklist with a comprehensive medical
evaluation; (2) that each individual
reports to FMCSA within 2 business
days of occurrence, all episodes of
severe hypoglycemia, significant
complications, or inability to manage
diabetes; also, any involvement in an
accident or any other adverse event in
a CMV or personal vehicle, whether or
not they are related to an episode of
hypoglycemia; (3) that each individual
provide a copy of the ophthalmologist’s
or optometrist’s report to the medical
examiner at the time of the annual
medical examination; and (4) that each
individual provide a copy of the annual
medical certification to the employer for
retention in the driver’s qualification
file, or keep a copy in his/her driver’s
qualification file if he/she is selfemployed. The driver must also have a
copy of the certification when driving,
for presentation to a duly authorized
Federal, State, or local enforcement
official.
VerDate Aug<31>2005
17:50 Oct 21, 2008
Jkt 217001
Discussion of Comments
FMCSA received no comments in this
proceeding.
ACTION:
Conclusion
SUMMARY: FMCSA announces receipt of
applications from 39 individuals for
exemptions from the prohibition against
persons with insulin-treated diabetes
mellitus (ITDM) operating commercial
motor vehicles (CMVs) in interstate
commerce. If granted, the exemptions
would enable these individuals with
ITDM to operate commercial motor
vehicles in interstate commerce.
DATES: Comments must be received on
or before November 21, 2008.
ADDRESSES: You may submit comments
bearing the Federal Docket Management
System (FDMS) Docket ID FMCSA–
20078–0293 using any of the following
methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov. Follow the
on-line instructions for submitting
comments.
• Mail: Docket Management Facility;
U.S. Department of Transportation, 1200
New Jersey Avenue, SE., West Building
Ground Floor, Room W12–140,
Washington, DC 20590–0001.
• Hand Delivery: West Building
Ground Floor, Room W12–140, 1200
New Jersey Avenue, SE., Washington,
DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
• Fax: 1–202–493–2251.
Each submission must include the
Agency name and the docket ID for this
Notice. Note that DOT posts all
comments received without change to
https://www.regulations.gov, including
any personal information included in a
comment. Please see the Privacy Act
heading below.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov at any time or
Room W12–140 on the ground level of
the West Building, 1200 New Jersey
Avenue, SE., Washington, DC, between
9 a.m. and 5 p.m., Monday through
Friday, except Federal holidays. The
FDMS is available 24 hours each day,
365 days each year. If you want
acknowledgment that we received your
comments, please include a selfaddressed, stamped envelope or
postcard or print the acknowledgement
page that appears after submitting
comments on-line.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of our dockets by the
name of the individual submitting the
comment (or of the person signing the
comment, if submitted on behalf of an
association, business, labor union, etc.).
You may review the DOT’s complete
After considering the comments to the
docket, and based upon its evaluation of
the thirty-nine exemption applications,
FMCSA exempts, Joseph L. Bartolomei,
Michael B. Bennington, Sr., Keith A.
Callahan, John E. Coppedge, Roland D.
Demers, Gary J. Drackert, Larry J.
Eischens, James L. Erviti, Richard C.
Frost, Charles W. Garrison, Timothy W.
Goforth, Chad C. Gittings, David J.
Hanzl, John A. Hayes, Thomas R. Jones,
David H. Keawe, James G. Keesling,
Chadwick A. Lang, Barry D. Langley,
John M. Lyon, Douglas S. Morical,
Robert L. O’Neill, Barry S. Neukum,
Mark E. Peters, Brian M. Rossiter, Roger
M. Russell, John G. Schaible, Jr., Rory J.
Seleman, Thomas P. Shergold,
Kristopher R. Soto, Frank L. Tomlinson,
Eric D. Travland, Ralph E. Vindittie,
James E. Waller, III, Chase M. Wells,
Laurie E. White, Robert E. Williams,
Craig E. Wolf, and Stephanie D. Wright
from the ITDM standard in 49 CFR
391.41(b)(3), subject to the conditions
listed under ‘‘Conditions and
Requirements’’ above.
In accordance with 49 U.S.C. 31136(e)
and 31315 each exemption will be valid
for two years unless revoked earlier by
FMCSA. The exemption will be revoked
if: (1) The person fails to comply with
the terms and conditions of the
exemption; (2) the exemption has
resulted in a lower level of safety than
was maintained before it was granted; or
(3) continuation of the exemption would
not be consistent with the goals and
objectives of 49 U.S.C. 31136(e) and
31315. If the exemption is still effective
at the end of the 2-year period, the
person may apply to FMCSA for a
renewal under procedures in effect at
that time.
Issued on October 14, 2008.
Larry W. Minor,
Associate Administrator for Policy and
Program Development.
[FR Doc. E8–25172 Filed 10–21–08; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket ID. FMCSA–2008–0293]
Qualification of Drivers; Exemption
Applications; Diabetes
Federal Motor Carrier Safety
Administration (FMCSA).
AGENCY:
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
Notice of applications for
exemptions from the diabetes standard;
request for comments.
E:\FR\FM\22OCN1.SGM
22OCN1
Agencies
[Federal Register Volume 73, Number 205 (Wednesday, October 22, 2008)]
[Notices]
[Pages 63041-63042]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25172]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[FMCSA Docket No. FMCSA-2008-0267]
Qualification of Drivers; Exemption Applications; Diabetes
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to exempt thirty-nine individuals
from its rule prohibiting persons with insulin-treated diabetes
mellitus (ITDM) from operating commercial motor vehicles (CMVs) in
interstate commerce. The exemptions will enable these individuals to
operate CMVs in interstate commerce.
DATES: The exemptions are effective October 22, 2008. The exemptions
expire on October 22, 2010.
FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Director, Medical
Programs, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Room W64-224,
Department of Transportation, 1200 New Jersey Avenue, SE., Washington,
DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., Monday
through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online through the Federal Document
Management System (FDMS) at: https://www.regulations.gov.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue, SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the electronic form of all comments
received into any of DOT's dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, or other
entity). You may review DOT's complete Privacy Act Statement in the
Federal Register (65 FR 19476, Apr. 11, 2000). This statement is also
available at https://Docketsinfo.dot.gov.
Background
On September 9, 2008, FMCSA published a notice announcing receipt
of applications for exemption from the Federal diabetes standard from
thirty-nine individuals, and requested comments from the public (73 FR
52451). The public comment period closed on October 9, 2008, and no
comments were received.
FMCSA has evaluated the eligibility of the thirty-nine applicants
and determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to, or greater than, the level
that would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).
Diabetes Mellitus and Driving Experience of the Applicants
The Agency established the current standard for diabetes in 1970
because several risk studies indicated that diabetic drivers had a
higher rate of crash involvement than the general population. The
diabetes rule provides that ``A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control'' (49 CFR 391.41(b)(3)).
FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible. The 2003 Notice (68 FR 52442) in conjunction
with the November 8, 2005 (70 FR 67777) Federal Register Notice
provides the current protocol for allowing such drivers to operate CMVs
in interstate commerce.
These thirty-nine applicants have had ITDM over a range of 1 to 24
years. These applicants report no hypoglycemic reaction that resulted
in loss of consciousness or seizure, that required the assistance of
another person, or that resulted in impaired cognitive function without
warning symptoms in the past 5 years (with one year of stability
following any such episode). In each case, an endocrinologist has
verified that the driver has demonstrated willingness to properly
monitor and manage his or her diabetes, received education related to
diabetes management, and is on a stable insulin regimen. Each driver
reports no other disqualifying conditions, including diabetes-related
complications. Each meets the vision standard at 49 CFR 391.41(b)(10).
[[Page 63042]]
The qualifications and medical condition of each applicant were
stated and discussed in detail in the September 9, 2008, Federal
Register Notice (73 FR 52451). Therefore, they will not be repeated in
this notice.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes standard in 49 CFR 391.41(b)(3) if the exemption is
likely to achieve an equivalent or greater level of safety than would
be achieved without the exemption. The exemption allows the applicants
to operate CMVs in interstate commerce.
To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision and
reviewed the treating endocrinologist's medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
Consequently, FMCSA finds that exempting these applicants from the
diabetes standard in 49 CFR 391.41(b)(3) is likely to achieve a level
of safety equal to that existing without the exemption.
Conditions and Requirements
The terms and conditions of the exemption will be provided to the
applicants in the exemption document and they include the following:
(1) That each individual submits to FMCSA a quarterly monitoring
checklist completed by the treating endocrinologist as well as an
annual checklist with a comprehensive medical evaluation; (2) that each
individual reports to FMCSA within 2 business days of occurrence, all
episodes of severe hypoglycemia, significant complications, or
inability to manage diabetes; also, any involvement in an accident or
any other adverse event in a CMV or personal vehicle, whether or not
they are related to an episode of hypoglycemia; (3) that each
individual provide a copy of the ophthalmologist's or optometrist's
report to the medical examiner at the time of the annual medical
examination; and (4) that each individual provide a copy of the annual
medical certification to the employer for retention in the driver's
qualification file, or keep a copy in his/her driver's qualification
file if he/she is self-employed. The driver must also have a copy of
the certification when driving, for presentation to a duly authorized
Federal, State, or local enforcement official.
Discussion of Comments
FMCSA received no comments in this proceeding.
Conclusion
After considering the comments to the docket, and based upon its
evaluation of the thirty-nine exemption applications, FMCSA exempts,
Joseph L. Bartolomei, Michael B. Bennington, Sr., Keith A. Callahan,
John E. Coppedge, Roland D. Demers, Gary J. Drackert, Larry J.
Eischens, James L. Erviti, Richard C. Frost, Charles W. Garrison,
Timothy W. Goforth, Chad C. Gittings, David J. Hanzl, John A. Hayes,
Thomas R. Jones, David H. Keawe, James G. Keesling, Chadwick A. Lang,
Barry D. Langley, John M. Lyon, Douglas S. Morical, Robert L. O'Neill,
Barry S. Neukum, Mark E. Peters, Brian M. Rossiter, Roger M. Russell,
John G. Schaible, Jr., Rory J. Seleman, Thomas P. Shergold, Kristopher
R. Soto, Frank L. Tomlinson, Eric D. Travland, Ralph E. Vindittie,
James E. Waller, III, Chase M. Wells, Laurie E. White, Robert E.
Williams, Craig E. Wolf, and Stephanie D. Wright from the ITDM standard
in 49 CFR 391.41(b)(3), subject to the conditions listed under
``Conditions and Requirements'' above.
In accordance with 49 U.S.C. 31136(e) and 31315 each exemption will
be valid for two years unless revoked earlier by FMCSA. The exemption
will be revoked if: (1) The person fails to comply with the terms and
conditions of the exemption; (2) the exemption has resulted in a lower
level of safety than was maintained before it was granted; or (3)
continuation of the exemption would not be consistent with the goals
and objectives of 49 U.S.C. 31136(e) and 31315. If the exemption is
still effective at the end of the 2-year period, the person may apply
to FMCSA for a renewal under procedures in effect at that time.
Issued on October 14, 2008.
Larry W. Minor,
Associate Administrator for Policy and Program Development.
[FR Doc. E8-25172 Filed 10-21-08; 8:45 am]
BILLING CODE 4910-EX-P